HEADER EYE LENS PROTEIN 25-JUL-03 1OKI TITLE CRYSTAL STRUCTURE OF TRUNCATED HUMAN BETA-B1-CRYSTALLIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA CRYSTALLIN B1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CRYSTALLIN DOMAINS, RESIDUES 42-251; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: EYE LENS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS CRYSTALLIN, CATARACT, EYE LENS PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.L.M.VAN MONTFORT,O.A.BATEMAN,N.H.LUBSEN,C.SLINGSBY REVDAT 5 13-DEC-23 1OKI 1 LINK REVDAT 4 28-MAR-18 1OKI 1 SOURCE AUTHOR REVDAT 3 05-NOV-14 1OKI 1 REMARK VERSN SEQRES MODRES REVDAT 3 2 1 HET HETNAM HETSYN FORMUL REVDAT 3 3 1 LINK HETATM REVDAT 2 24-FEB-09 1OKI 1 VERSN REVDAT 1 22-JAN-04 1OKI 0 JRNL AUTH R.L.M.VAN MONTFORT,O.A.BATEMAN,N.H.LUBSEN,C.SLINGSBY JRNL TITL CRYSTAL STRUCTURE OF TRUNCATED HUMAN BETA-B1-CRYSTALLIN JRNL REF PROTEIN SCI. V. 12 2606 2003 JRNL REFN ISSN 0961-8368 JRNL PMID 14573871 JRNL DOI 10.1110/PS.03265903 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.29 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 87.1 REMARK 3 NUMBER OF REFLECTIONS : 55136 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2902 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3332 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE SET COUNT : 161 REMARK 3 BIN FREE R VALUE : 0.2810 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3039 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 423 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.14000 REMARK 3 B22 (A**2) : 0.14000 REMARK 3 B33 (A**2) : -0.29000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.074 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.075 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.050 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.260 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.973 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.967 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3154 ; 0.013 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2711 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4255 ; 1.242 ; 1.916 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6268 ; 0.782 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 364 ; 5.852 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 394 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3585 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 788 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 501 ; 0.178 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3367 ; 0.246 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 1884 ; 0.086 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 314 ; 0.155 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 1 ; 0.084 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 80 ; 0.281 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 38 ; 0.174 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1812 ; 1.557 ; 5.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2894 ; 2.499 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1342 ; 2.727 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1361 ; 4.170 ; 7.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. INITIAL DATASET PROCESSED IN P43212. TYR130 AT THE REMARK 3 CRYSTALLOGRAPHIC TWOFOLD CLASHED WITH TYR130 OF A SYMMETRY REMARK 3 RELATED MOLECULE. AS MOLECULE IS A DIMER IN SOLULTION, LOWERED REMARK 3 SPACE GROUP TO P43 WITH TWOFOLD NCS SYMMETRY. TYR130 POSSIBLY IN REMARK 3 TWO CONFORMATIONS. PRIMARY CONFORMATION MODELLED. REMARK 4 REMARK 4 1OKI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-JUL-03. REMARK 100 THE DEPOSITION ID IS D_1290013165. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.931 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60531 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.6 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2BB2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 31.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24-30% PEG4000, 0.1M TRIS/HCL PH 7.0 REMARK 280 -8.5, 0.2M MGCL2, PH 8.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 85.55550 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 128.33325 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 42.77775 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CRYSTALLINS FORM THE DOMINANT STRUCTURAL COMPONENTS REMARK 400 OF THE VERTEBRATE EYE LENS. THE PROTEIN EXISTS AS DIMERIC REMARK 400 OR HIGHER OLIGOMERIC FORMS. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 42 REMARK 465 VAL A 43 REMARK 465 PRO A 44 REMARK 465 ILE A 45 REMARK 465 THR A 46 REMARK 465 SER A 47 REMARK 465 ALA A 48 REMARK 465 LYS A 49 REMARK 465 ALA A 50 REMARK 465 ALA A 51 REMARK 465 GLU A 52 REMARK 465 LEU A 53 REMARK 465 HIS A 237 REMARK 465 LEU A 238 REMARK 465 GLU A 239 REMARK 465 GLY A 240 REMARK 465 SER A 241 REMARK 465 PHE A 242 REMARK 465 PRO A 243 REMARK 465 VAL A 244 REMARK 465 LEU A 245 REMARK 465 ALA A 246 REMARK 465 THR A 247 REMARK 465 GLU A 248 REMARK 465 PRO A 249 REMARK 465 PRO A 250 REMARK 465 LYS A 251 REMARK 465 THR B 42 REMARK 465 VAL B 43 REMARK 465 PRO B 44 REMARK 465 ILE B 45 REMARK 465 THR B 46 REMARK 465 SER B 47 REMARK 465 ALA B 48 REMARK 465 LYS B 49 REMARK 465 ALA B 50 REMARK 465 ALA B 51 REMARK 465 GLU B 52 REMARK 465 LEU B 53 REMARK 465 LEU B 238 REMARK 465 GLU B 239 REMARK 465 GLY B 240 REMARK 465 SER B 241 REMARK 465 PHE B 242 REMARK 465 PRO B 243 REMARK 465 VAL B 244 REMARK 465 LEU B 245 REMARK 465 ALA B 246 REMARK 465 THR B 247 REMARK 465 GLU B 248 REMARK 465 PRO B 249 REMARK 465 PRO B 250 REMARK 465 LYS B 251 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS B 237 CA C O CB CG ND1 CD2 REMARK 470 HIS B 237 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2088 O HOH B 2166 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 201 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 201 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL DBREF 1OKI A 42 251 UNP P53674 CRB1_HUMAN 42 251 DBREF 1OKI B 42 251 UNP P53674 CRB1_HUMAN 42 251 SEQRES 1 A 210 THR VAL PRO ILE THR SER ALA LYS ALA ALA GLU LEU PRO SEQRES 2 A 210 PRO GLY ASN TYR ARG LEU VAL VAL PHE GLU LEU GLU ASN SEQRES 3 A 210 PHE GLN GLY ARG ARG ALA GLU PHE SER GLY GLU CSD SER SEQRES 4 A 210 ASN LEU ALA ASP ARG GLY PHE ASP ARG VAL ARG SER ILE SEQRES 5 A 210 ILE VAL SER ALA GLY PRO TRP VAL ALA PHE GLU GLN SER SEQRES 6 A 210 ASN PHE ARG GLY GLU MET PHE ILE LEU GLU LYS GLY GLU SEQRES 7 A 210 TYR PRO ARG TRP ASN THR TRP SER SER SER TYR ARG SER SEQRES 8 A 210 ASP ARG LEU MET SER PHE ARG PRO ILE LYS MET ASP ALA SEQRES 9 A 210 GLN GLU HIS LYS ILE SER LEU PHE GLU GLY ALA ASN PHE SEQRES 10 A 210 LYS GLY ASN THR ILE GLU ILE GLN GLY ASP ASP ALA PRO SEQRES 11 A 210 SER LEU TRP VAL TYR GLY PHE SER ASP ARG VAL GLY SER SEQRES 12 A 210 VAL LYS VAL SER SER GLY THR TRP VAL GLY TYR GLN TYR SEQRES 13 A 210 PRO GLY TYR ARG GLY TYR GLN TYR LEU LEU GLU PRO GLY SEQRES 14 A 210 ASP PHE ARG HIS TRP ASN GLU TRP GLY ALA PHE GLN PRO SEQRES 15 A 210 GLN MET GLN SER LEU ARG ARG LEU ARG ASP LYS GLN TRP SEQRES 16 A 210 HIS LEU GLU GLY SER PHE PRO VAL LEU ALA THR GLU PRO SEQRES 17 A 210 PRO LYS SEQRES 1 B 210 THR VAL PRO ILE THR SER ALA LYS ALA ALA GLU LEU PRO SEQRES 2 B 210 PRO GLY ASN TYR ARG LEU VAL VAL PHE GLU LEU GLU ASN SEQRES 3 B 210 PHE GLN GLY ARG ARG ALA GLU PHE SER GLY GLU CSD SER SEQRES 4 B 210 ASN LEU ALA ASP ARG GLY PHE ASP ARG VAL ARG SER ILE SEQRES 5 B 210 ILE VAL SER ALA GLY PRO TRP VAL ALA PHE GLU GLN SER SEQRES 6 B 210 ASN PHE ARG GLY GLU MET PHE ILE LEU GLU LYS GLY GLU SEQRES 7 B 210 TYR PRO ARG TRP ASN THR TRP SER SER SER TYR ARG SER SEQRES 8 B 210 ASP ARG LEU MET SER PHE ARG PRO ILE LYS MET ASP ALA SEQRES 9 B 210 GLN GLU HIS LYS ILE SER LEU PHE GLU GLY ALA ASN PHE SEQRES 10 B 210 LYS GLY ASN THR ILE GLU ILE GLN GLY ASP ASP ALA PRO SEQRES 11 B 210 SER LEU TRP VAL TYR GLY PHE SER ASP ARG VAL GLY SER SEQRES 12 B 210 VAL LYS VAL SER SER GLY THR TRP VAL GLY TYR GLN TYR SEQRES 13 B 210 PRO GLY TYR ARG GLY TYR GLN TYR LEU LEU GLU PRO GLY SEQRES 14 B 210 ASP PHE ARG HIS TRP ASN GLU TRP GLY ALA PHE GLN PRO SEQRES 15 B 210 GLN MET GLN SER LEU ARG ARG LEU ARG ASP LYS GLN TRP SEQRES 16 B 210 HIS LEU GLU GLY SER PHE PRO VAL LEU ALA THR GLU PRO SEQRES 17 B 210 PRO LYS MODRES 1OKI CSD A 79 CYS 3-SULFINOALANINE MODRES 1OKI CSD B 79 CYS 3-SULFINOALANINE HET CSD A 79 8 HET CSD B 79 8 HETNAM CSD 3-SULFINOALANINE HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE FORMUL 1 CSD 2(C3 H7 N O4 S) FORMUL 3 HOH *423(H2 O) HELIX 1 1 SER A 106 PHE A 108 5 3 HELIX 2 2 ARG A 122 SER A 127 1 6 HELIX 3 3 ALA A 156 PHE A 158 5 3 HELIX 4 4 SER A 172 GLY A 177 5 6 HELIX 5 5 HIS A 214 GLY A 219 5 6 HELIX 6 6 SER B 106 PHE B 108 5 3 HELIX 7 7 ARG B 122 SER B 127 1 6 HELIX 8 8 ALA B 156 PHE B 158 5 3 HELIX 9 9 SER B 172 GLY B 177 5 6 HELIX 10 10 HIS B 214 GLY B 219 5 6 SHEET 1 AA 4 GLN A 69 PHE A 75 0 SHEET 2 AA 4 ARG A 59 LEU A 65 -1 O LEU A 60 N PHE A 75 SHEET 3 AA 4 SER A 92 ALA A 97 -1 O SER A 92 N PHE A 63 SHEET 4 AA 4 GLY A 118 TYR A 120 -1 O GLY A 118 N VAL A 95 SHEET 1 AB 3 ARG A 109 LEU A 115 0 SHEET 2 AB 3 TRP A 100 GLN A 105 -1 O TRP A 100 N LEU A 115 SHEET 3 AB 3 SER A 137 PRO A 140 -1 O SER A 137 N PHE A 103 SHEET 1 AC 4 LYS A 159 GLN A 166 0 SHEET 2 AC 4 LYS A 149 GLY A 155 -1 O ILE A 150 N ILE A 165 SHEET 3 AC 4 SER A 184 SER A 189 -1 O SER A 184 N PHE A 153 SHEET 4 AC 4 GLY A 210 PHE A 212 -1 O GLY A 210 N VAL A 187 SHEET 1 AD 3 ARG A 201 LEU A 207 0 SHEET 2 AD 3 THR A 191 TYR A 197 -1 O TRP A 192 N LEU A 207 SHEET 3 AD 3 SER A 227 LEU A 231 -1 O SER A 227 N TYR A 195 SHEET 1 BA 4 GLN B 69 PHE B 75 0 SHEET 2 BA 4 ARG B 59 LEU B 65 -1 O LEU B 60 N PHE B 75 SHEET 3 BA 4 SER B 92 ALA B 97 -1 O SER B 92 N PHE B 63 SHEET 4 BA 4 GLY B 118 TYR B 120 -1 O GLY B 118 N VAL B 95 SHEET 1 BB 3 ARG B 109 LEU B 115 0 SHEET 2 BB 3 TRP B 100 GLN B 105 -1 O TRP B 100 N LEU B 115 SHEET 3 BB 3 SER B 137 PRO B 140 -1 O SER B 137 N PHE B 103 SHEET 1 BC 4 LYS B 159 GLN B 166 0 SHEET 2 BC 4 LYS B 149 GLY B 155 -1 O ILE B 150 N ILE B 165 SHEET 3 BC 4 SER B 184 SER B 189 -1 O SER B 184 N PHE B 153 SHEET 4 BC 4 GLY B 210 PHE B 212 -1 O GLY B 210 N VAL B 187 SHEET 1 BD 3 ARG B 201 LEU B 207 0 SHEET 2 BD 3 THR B 191 TYR B 197 -1 O TRP B 192 N LEU B 207 SHEET 3 BD 3 SER B 227 LEU B 231 -1 O SER B 227 N TYR B 195 LINK C GLU A 78 N CSD A 79 1555 1555 1.33 LINK C CSD A 79 N SER A 80 1555 1555 1.33 LINK C GLU B 78 N CSD B 79 1555 1555 1.33 LINK C CSD B 79 N SER B 80 1555 1555 1.33 CISPEP 1 GLY A 98 PRO A 99 0 -0.18 CISPEP 2 GLY B 98 PRO B 99 0 1.14 CRYST1 45.040 45.040 171.111 90.00 90.00 90.00 P 43 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022202 0.000000 0.000000 0.00000 SCALE2 0.000000 0.022202 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005844 0.00000 MTRIX1 1 -0.000100 -1.000000 -0.000300 67.56230 1 MTRIX2 1 -1.000000 0.000100 0.000100 67.55940 1 MTRIX3 1 -0.000100 0.000300 -1.000000 12.94830 1